Preclinical Alzheimer disease: brain oxidative stress, Abeta peptide and proteomics. - sprookjes - yvandenbroek - TriplyDB

Preclinical Alzheimer disease: brain oxidative stress, Abeta peptide and proteomics.

Preclinical Alzheimer disease: brain oxidative stress, Abeta peptide and proteomics.

http://www.wikidata.org/entity/Q33912803

about

Phosphodiesterase-5 Inhibitors: Action on the Signaling Pathways of Neuroinflammation, Neurodegeneration, and Cognition The 2013 SFRBM discovery award: selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairment Effects of Fe(II)/H2O2 oxidation on ubiquitin conformers measured by ion mobility-mass spectrometry.Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer's Disease Prevention and Early Intervention Oxidatively modified nucleic acids in preclinical Alzheimer's disease (PCAD) brain.Biomarkers of lipid peroxidation in Alzheimer disease (AD): an update.The earliest stage of cognitive impairment in transition from normal aging to Alzheimer disease is marked by prominent RNA oxidation in vulnerable neurons.4-Hydroxyhexenal (HHE) impairs glutamate transport in astrocyte cultures Redox Proteomic Profiling of Specifically Carbonylated Proteins in the Serum of Triple Transgenic Alzheimer's Disease Mice.Amyloid-β toxicity and tau hyperphosphorylation are linked via RCAN1 in Alzheimer's disease.Epigenetic changes in the progression of Alzheimer's disease.Impairment of proteostasis network in Down syndrome prior to the development of Alzheimer's disease neuropathology: redox proteomics analysis of human brain.Oxidative stress and β-amyloid protein in Alzheimer's disease.How can we improve clinical trials in amyotrophic lateral sclerosis?Elevation of glutathione as a therapeutic strategy in Alzheimer disease.4-Hydroxy-2-nonenal, a reactive product of lipid peroxidation, and neurodegenerative diseases: a toxic combination illuminated by redox proteomics studies Road to Alzheimer's disease: the pathomechanism underlying.Oxidative damage to RNA in aging and neurodegenerative disorders.Lipid peroxidation triggers neurodegeneration: a redox proteomics view into the Alzheimer disease brain.Telomere shortening and Alzheimer's disease.Oligodendrocytes and Alzheimer's disease.Are Polyphenols Strong Dietary Agents Against Neurotoxicity and Neurodegeneration?Effects of estrogen on beta-amyloid-induced cholinergic cell death in the nucleus basalis magnocellularis.Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD.Homogenous and Microbeam X-Ray Radiation Induces Proteomic Changes in the Brains of Irradiated Rats and in the Brains of Nonirradiated Cage Mate Rats.Atorvastatin Prevents Cognitive Deficits Induced by Intracerebroventricular Amyloid-β1-40 Administration in Mice: Involvement of Glutamatergic and Antioxidant Systems.Hippocampal Proteomic Analysis Reveals Distinct Pathway Deregulation Profiles at Early and Late Stages in a Rat Model of Alzheimer's-Like Amyloid Pathology.Quantitative phosphoproteomic analyses of the inferior parietal lobule from three different pathological stages of Alzheimer's disease.Heme Oxygenase-1 Activity as a Correlate to Exercise-Mediated Amelioration of Cognitive Decline and Neuropathological Alterations in an Aging Rat Model of Dementia.

P2860

Q26771954-0927D1E5-BEFB-47A9-AFC6-24876B75B307 Q26827320-60B9F53F-6202-4FD1-8ECB-0CA8C6DC4BBD Q30424397-4EF31541-D110-4CDF-ACD1-0A1F05478B9F Q33838291-1215CC1B-D9EA-4E0A-8866-BB58818A0F3B Q35286714-217A5E0C-C92A-42D3-8DE7-40F230AE5FF3 Q35738877-C40F9EAA-5800-4CA0-AB8C-4482860FAAA6 Q35783379-134C3689-17A6-4770-ACAA-54B39B2C8F96 Q36821506-3FDFE3B1-192C-4267-8846-E5157C79C443 Q36846943-BF71AD88-C571-4847-B857-C749D0646323 Q36949391-E1BA7A70-38DD-45DF-BAC1-30E114384912 Q37378037-0D7AAFB9-B729-4011-8D25-66A9D529705E Q37613081-D6CF7D42-552A-4518-8C81-618F7901BAED Q37928994-09B7F251-0FF4-41DB-A8A2-A6087ED7DC6B Q37938694-AA9111CC-FBDC-4BFB-B2ED-E14AFEF0BC69 Q37947939-CCAD8072-ABA4-438D-BAB3-87438AC52120 Q37960537-094B5E50-B4DA-41CB-A044-4A4321D6B6EB Q37972068-39843082-7BEB-4A11-A0D6-31A6C5FEAB9C Q38016374-84BBE431-3D82-4DE5-A26C-D3AF34EE94FD Q38050263-FC3BE5D4-0731-4DEB-8D46-84B0F635EC99 Q38060615-10DCDB42-9C50-41D4-8642-078350BE2FE5 Q38497880-D5406C86-42BA-46A7-AB40-05A433519635 Q38690585-BC6E7251-0342-4CEC-9DA6-BF216FB412FB Q42478187-DA6DF61F-0292-4E60-A96B-F964B059C47C Q46778500-E616C9F0-6735-4E0F-8FA0-AD657DBEEFAF Q47830585-6A806A8C-60B5-4B22-A1D1-98A0420B0F4B Q48253206-113E5E70-4F47-4227-861F-24EA1F7DA63F Q48604859-966B319C-910E-4714-97FD-59C8C1C80F22 Q50556789-3D2AF10E-8381-4449-A4DD-BD9135E40107 Q53692344-6832C01E-65E2-4F94-A296-CC3B93C5A9A4

P2860

Preclinical Alzheimer disease: brain oxidative stress, Abeta peptide and proteomics.

http://www.wikidata.org/entity/Q33912803

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Preclinical Alzheimer disease: brain oxidative stress, Abeta peptide and proteomics.

@ast

Preclinical Alzheimer disease: brain oxidative stress, Abeta peptide and proteomics.

@en

type

label

Preclinical Alzheimer disease: brain oxidative stress, Abeta peptide and proteomics.

@ast

Preclinical Alzheimer disease: brain oxidative stress, Abeta peptide and proteomics.

@en

prefLabel

Preclinical Alzheimer disease: brain oxidative stress, Abeta peptide and proteomics.

@ast

Preclinical Alzheimer disease: brain oxidative stress, Abeta peptide and proteomics.

@en

P1433

Q33912803-A7A7A8A8-714F-4DED-8C72-CC09C3CCEDC2

P1476

Q33912803-8FE759C4-9776-45C3-9133-6E7FF380BCA4

P2093

Q33912803-0947BF88-94D4-4F5E-8EDD-4F7381547B41

Q33912803-3A312BA9-776F-484F-A510-050A0F93D1D3

Q33912803-70532014-EC46-4DBF-A984-E9B6B81B1D2F

Q33912803-802C304A-8938-4416-80B2-7AEE74295ED1

Q33912803-971F229F-0C3D-411D-A2CF-F7707E17260B

Q33912803-AA089E22-01B9-40CA-901F-496EA2421160

Q33912803-F8C6E035-B91B-4F63-A0C3-7B9EEADD6B51

P2860

Q33912803-02920C73-E834-4569-93FC-92BEB22880EC

Q33912803-042FAE61-0CA1-48FD-8DD7-3B93F6D68249

Q33912803-07280879-E621-4160-82C7-4B350A1C978F

Q33912803-07C3BFE1-1DF9-4CAD-B2A0-19E6E92A2FAC

Q33912803-0A42E374-59B6-453F-B644-FC6C623F3CE3

Q33912803-0AA8F229-E9FE-44F2-B8A3-576DA3F4613D

Q33912803-11B62246-F37C-4D90-997F-7ABE582A8516

Q33912803-11F444EE-25DB-4E7D-910D-AC1E0F7F252D

Q33912803-1258CB73-8817-42F8-815A-7D9D37257D87

Q33912803-12C4620C-40D1-4F77-BA4C-809D9FB1E46B

P304

Q33912803-1FA70751-CFEF-4A63-AB50-84D99EEE108D

P31

Q33912803-527F8265-9862-44B6-8E57-40B4FE396E2C

P356

Q33912803-6D1D42E5-D70D-4741-8D09-1A0D28304FD3

P433

Q33912803-F23893D0-98BE-463C-83AB-F20E318E41EA

P478

Q33912803-01C53315-F648-45C0-A2F0-234C27412B8B

P50

Q33912803-1779927E-47A6-4725-BBCA-D86F71528459

P577

Q33912803-E5A9FA65-964D-4994-A037-164374D69E24

P5875

Q33912803-C2C1E8E0-CF72-49FD-A6D7-F9B4DB9DE51B

P698

Q33912803-7A58E915-B43C-4E38-BF17-ED8CD76A9539

P921

Q33912803-4D11E154-E6F1-4819-9138-793962FF2C54

P932

Q33912803-7BCAD33B-414A-4CA7-9C49-4A3634316A54

P356

J.NBD.2010.04.011

P1433

Neurobiology of Disease

P1476

Preclinical Alzheimer disease: brain oxidative stress, Abeta peptide and proteomics.

@en

P2093

Christopher D Aluise

http://www.w3.org/2001/XMLSchema#string

Jian Cai

http://www.w3.org/2001/XMLSchema#string

M Paul Murphy

http://www.w3.org/2001/XMLSchema#string

Renã A Sowell Robinson

http://www.w3.org/2001/XMLSchema#string

Tina L Beckett

http://www.w3.org/2001/XMLSchema#string

William M Pierce

http://www.w3.org/2001/XMLSchema#string

William R Markesbery

http://www.w3.org/2001/XMLSchema#string

P2860

The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production

The essential mitotic peptidyl-prolyl isomerase Pin1 binds and regulates mitosis-specific phosphoproteins

Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake

Identification of septins in neurofibrillary tangles in Alzheimer's disease

A human peptidyl-prolyl isomerase essential for regulation of mitosis

Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide

Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity

Processing of the pre-beta-amyloid protein by cathepsin D is enhanced by a familial Alzheimer's disease mutation

Absence of the mid-sized neurofilament subunit decreases axonal calibers, levels of light neurofilament (NF-L), and neurofilament content

P304

221-228

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NBD.2010.04.011

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

39

http://www.w3.org/2001/XMLSchema#string

P50

D Allan Butterfield

P577

2010-04-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43182442

http://www.w3.org/2001/XMLSchema#string

P698

20399861

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

2885559

http://www.w3.org/2001/XMLSchema#string